After Hours
$
10.86
Change
-0.03 -0.28%
Volume
Volume 74,629
Feb 7, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 11.09
$ 10.89
Change
-0.20 -1.80%
Day low
Day high
$10.61
$11.20

52 week low
52 week high
$8.75
$95.34

Market cap
$942.69M
Average volume
7.53M
P/E ratio
N/A
Rev. per Employee
$1.13M
EPS
-17.35
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on NVAX
-
Novavax Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Novavax Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Novavax Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Novavax Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock rises Friday, outperforms market
- MarketWatch Automation
-
Novavax Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Novavax Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Job Cuts Today, What Tomorrow? Big Tech Faces Some Big Tests.
- Barron's Online
-
Novavax Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock rises Friday, outperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
Other News on NVAX
-
FDA Advisers Back Annual Covid-19 Boosters With Reservations About Rollout
- The Wall Street Journal Interactive Edition
-
New Covid-19 Booster Shots For This Fall: What to Know
- The Wall Street Journal Interactive Edition
-
Top 5 3rd Quarter Trades of HIGHBRIDGE CAPITAL MANAGEMENT LLC
- GuruFocus.com
-
U.S. COVID health emergency to stay in place
- Seeking Alpha
-
Novavax COVID-19 shot authorized as booster in UK
- Seeking Alpha
-
Novavax, Inc. (NVAX) Q3 2022 Earnings Call Transcript
- Seeking Alpha
- Loading more headlines...
Press Releases on NVAX
-
Novavax NVAX Investment Report
- Stock Traders Daily
-
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
- PR Newswire - PRF
-
- Stock Traders Daily
-
Novavax Names John C. Jacobs as New President & Chief Executive Officer
- PR Newswire - PRF
-
Vaccine Market Research Report: Growth, Top Companies Share, Size, and Forecast 2022-2027
- SUPER MARKET RESEARCH
-
- Stock Traders Daily
-
4 stocks to watch on Wednesday: Apple, Pfizer, and others
- PressReach.com
-
How the price action of Novavax (NVAX) is used to our Advantage
- Stock Traders Daily
-
Novavax Announces Pricing of $65 Million Public Offering of Common Stock
- PR Newswire - PRF
-
Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes
- PR Newswire - PRF
-
Novavax Plummets on Stock Offering
- Baystreet.ca
-
Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
- PR Newswire - PRF
-
Novavax Announces Proposed $125 Million Public Offering of Common Stock
- PR Newswire - PRF
-
Trading Novavax NVAX With Integrated Risk Controls
- Stock Traders Daily
-
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com